Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 2Lymphoid 2Genitourinary 2Tumor-Agnostic 1NET 1Endocrine 1

Conditions

Neoplastic Cells, Circulating 1Neoplasms 1Lung Neoplasms 1Lung Cancer Metastatic 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Needles × Thoracic × Clear all
NCT05706883 2024-04-05

ProphetaPro

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Completed
348 enrolled
Thoracic

Lung Cancer Metastatic

NCT02507778 2016-09-23

Circulating Tumor Cells Spillage After Pulmonary Biopsy

Rabin Medical Center

Phase NA Unknown
40 enrolled
Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡